• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为阿尔茨海默病的数字生物标志物,对记忆相似性任务的认知建模。

Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease.

机构信息

Department of Neurobiology and Behavior, 1424 Biological Sciences III, University of California, Irvine, Irvine, California, USA.

Department of Cognitive Science, 3151 Social Sciences Plaza A, University of California, Irvine, Irvine, California, USA.

出版信息

Alzheimers Dement. 2024 Oct;20(10):6935-6947. doi: 10.1002/alz.14163. Epub 2024 Sep 6.

DOI:10.1002/alz.14163
PMID:39239893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11485396/
Abstract

BACKGROUND

The Mnemonic Similarity Task (MST) is a popular memory task designed to assess hippocampal integrity. We assessed whether analyzing MST performance using a multinomial processing tree (MPT) cognitive model could detect individuals with elevated Alzheimer's disease (AD) biomarker status prior to cognitive decline.

METHOD

We analyzed MST data from >200 individuals (young, cognitively healthy older adults and individuals with mild cognitive impairment [MCI]), a subset of which also had existing cerebrospinal fluid (CSF) amyloid beta (Aβ) and phosphorylated tau (pTau) data using both traditional and model-derived approaches. We assessed how well each could predict age group, memory ability, MCI status, Aβ, and pTau status using receiver operating characteristic analyses.

RESULTS

Both approaches predicted age group membership equally, but MPT-derived metrics exceeded traditional metrics in all other comparisons.

DISCUSSION

A MPT model of the MST can detect individuals with AD prior to cognitive decline, making it a potentially useful tool for screening and monitoring older adults during the asymptomatic phase of AD.

HIGHLIGHTS

The MST, along with cognitive modeling, identifies individuals with memory deficits and cognitive impairment. Cognitive modeling of the MST identifies individuals with increased AD biomarkers prior to changes in cognitive function. The MST is a digital biomarker that identifies individuals at high risk of AD.

摘要

背景

记忆符相似性任务(MST)是一种流行的记忆任务,旨在评估海马体的完整性。我们评估了使用多项处理树(MPT)认知模型分析 MST 性能是否可以在认知能力下降之前发现阿尔茨海默病(AD)生物标志物水平升高的个体。

方法

我们分析了来自> 200 名个体(年轻、认知健康的老年人和轻度认知障碍 [MCI] 个体)的 MST 数据,其中一部分也有现有的脑脊液(CSF)淀粉样蛋白β(Aβ)和磷酸化 tau(pTau)数据,使用传统和模型衍生的方法。我们使用接收者操作特征分析评估了每种方法预测年龄组、记忆能力、MCI 状态、Aβ 和 pTau 状态的能力。

结果

两种方法预测年龄组的能力相当,但 MPT 衍生的指标在所有其他比较中均优于传统指标。

讨论

MST 的 MPT 模型可以在认知能力下降之前识别出 AD 患者,使其成为筛查和监测 AD 无症状期老年人的潜在有用工具。

重点

MST 与认知建模一起,可以识别出有记忆缺陷和认知障碍的个体。MST 的认知建模可以在认知功能发生变化之前识别出 AD 生物标志物增加的个体。MST 是一种数字生物标志物,可以识别出 AD 风险较高的个体。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/9ba5aa96530f/ALZ-20-6935-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/623a91c3665f/ALZ-20-6935-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/60ddad031b81/ALZ-20-6935-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/21621e085fe4/ALZ-20-6935-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/5eb583448335/ALZ-20-6935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/9ba5aa96530f/ALZ-20-6935-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/623a91c3665f/ALZ-20-6935-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/60ddad031b81/ALZ-20-6935-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/21621e085fe4/ALZ-20-6935-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/5eb583448335/ALZ-20-6935-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dc40/11485396/9ba5aa96530f/ALZ-20-6935-g005.jpg

相似文献

1
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's disease.作为阿尔茨海默病的数字生物标志物,对记忆相似性任务的认知建模。
Alzheimers Dement. 2024 Oct;20(10):6935-6947. doi: 10.1002/alz.14163. Epub 2024 Sep 6.
2
Cognitive modeling of the Mnemonic Similarity Task as a digital biomarker for Alzheimer's Disease.作为阿尔茨海默病数字生物标志物的记忆相似性任务的认知建模
bioRxiv. 2024 Mar 11:2024.03.07.584012. doi: 10.1101/2024.03.07.584012.
3
Accelerated inflammatory aging in Alzheimer's disease and its relation to amyloid, tau, and cognition.阿尔茨海默病中的加速炎症性衰老及其与淀粉样蛋白、tau蛋白和认知的关系。
Sci Rep. 2021 Jan 21;11(1):1965. doi: 10.1038/s41598-021-81705-7.
4
Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.血液磷酸化 tau 181 作为阿尔茨海默病的生物标志物:使用来自四个前瞻性队列的数据进行的诊断性能和预测模型研究。
Lancet Neurol. 2020 May;19(5):422-433. doi: 10.1016/S1474-4422(20)30071-5.
5
ApoE4 effects on automated diagnostic classifiers for mild cognitive impairment and Alzheimer's disease.载脂蛋白E4对轻度认知障碍和阿尔茨海默病自动诊断分类器的影响。
Neuroimage Clin. 2014 Jan 4;4:461-72. doi: 10.1016/j.nicl.2013.12.012. eCollection 2014.
6
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.数字认知评估作为预测阿尔茨海默病谱系中未来认知能力下降和 tau 积累的低负担标志物。
Alzheimers Dement. 2024 Oct;20(10):6881-6895. doi: 10.1002/alz.14154. Epub 2024 Sep 6.
7
Reciprocal Predictive Relationships between Amyloid and Tau Biomarkers in Alzheimer's Disease Progression: An Empirical Model.阿尔茨海默病进展中淀粉样蛋白和 tau 生物标志物的相互预测关系:一个经验模型。
J Neurosci. 2019 Sep 11;39(37):7428-7437. doi: 10.1523/JNEUROSCI.1056-19.2019. Epub 2019 Jul 26.
8
Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.泰国诗里拉吉医院对阿尔茨海默病(AD)及其他痴呆症患者的脑脊液(CSF)β-淀粉样蛋白(1-42)、磷酸化tau蛋白(ptau-181)和总tau蛋白进行评估。
J Med Assoc Thai. 2011 Feb;94 Suppl 1:S77-83.
9
Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.比较多种 tau-PET 指标作为衰老和阿尔茨海默病的生物标志物。
Neuroimage. 2017 Aug 15;157:448-463. doi: 10.1016/j.neuroimage.2017.05.058. Epub 2017 Jun 3.
10
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies.淀粉样蛋白和 Tau 预测认知和功能下降在认知正常的老年人:来自 A4 和 LEARN 研究的纵向数据。
J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.

引用本文的文献

1
Identifying dementia neuropathology using low-burden clinical data.利用低负荷临床数据识别痴呆症神经病理学
Alzheimers Dement. 2025 Aug;21(8):e70539. doi: 10.1002/alz.70539.
2
Development of a Cohesive Predictive Model for Substance Use Disorder Rehabilitation Using Passive Digital Biomarkers, Psychological Assessments, and Automated Facial Emotion Recognition: Protocol for a Prospective Cohort Study.使用被动数字生物标志物、心理评估和自动面部情绪识别开发物质使用障碍康复的连贯预测模型:一项前瞻性队列研究方案
JMIR Res Protoc. 2025 Jun 27;14:e71374. doi: 10.2196/71374.
3
Time Course and Severity of Cognitive Changes as a Function of Aβ Positivity and Genotype in Alzheimer Disease.

本文引用的文献

1
A response time model of the three-choice Mnemonic Similarity Task provides stable, mechanistically interpretable individual-difference measures.三选一记忆相似性任务的反应时间模型提供了稳定的、可从机制上解释的个体差异测量方法。
Front Hum Neurosci. 2024 Aug 29;18:1379287. doi: 10.3389/fnhum.2024.1379287. eCollection 2024.
2
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.数字认知评估作为预测阿尔茨海默病谱系中未来认知能力下降和 tau 积累的低负担标志物。
Alzheimers Dement. 2024 Oct;20(10):6881-6895. doi: 10.1002/alz.14154. Epub 2024 Sep 6.
3
阿尔茨海默病中认知变化的时间进程和严重程度与β淀粉样蛋白(Aβ)阳性及基因型的关系
Neurology. 2025 Jul 22;105(2):e213853. doi: 10.1212/WNL.0000000000213853. Epub 2025 Jun 27.
4
Integrating plasma p-tau217 and digital cognitive assessments for early detection in Alzheimer's disease.整合血浆p-tau217和数字认知评估用于阿尔茨海默病的早期检测。
Alzheimers Dement. 2025 Jun;21(6):e70355. doi: 10.1002/alz.70355.
5
Integrating Plasma pTau-217 and Digital Cognitive Assessments for Early Detection in Alzheimer's Disease.整合血浆pTau-217与数字认知评估用于阿尔茨海默病的早期检测
medRxiv. 2025 Mar 4:2025.03.03.25323297. doi: 10.1101/2025.03.03.25323297.
6
APOE4 Increases Susceptibility to Amyloid, Accelerating Episodic Memory Decline.APOE4增加对淀粉样蛋白的易感性,加速情景记忆衰退。
bioRxiv. 2024 Dec 24:2024.12.23.630203. doi: 10.1101/2024.12.23.630203.
7
Amyloid-β deposition in basal frontotemporal cortex is associated with selective disruption of temporal mnemonic discrimination.基底额颞叶皮质中的β-淀粉样蛋白沉积与颞叶记忆辨别能力的选择性破坏有关。
bioRxiv. 2024 Aug 26:2024.08.23.609449. doi: 10.1101/2024.08.23.609449.
8
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.数字认知评估作为预测阿尔茨海默病谱系中未来认知能力下降和 tau 积累的低负担标志物。
Alzheimers Dement. 2024 Oct;20(10):6881-6895. doi: 10.1002/alz.14154. Epub 2024 Sep 6.
9
Digital cognitive assessments as low-burden markers for predicting future cognitive decline and tau accumulation across the Alzheimer's spectrum.数字认知评估作为预测阿尔茨海默病谱系中未来认知衰退和tau蛋白积累的低负担标志物。
bioRxiv. 2024 May 26:2024.05.23.595638. doi: 10.1101/2024.05.23.595638.
Bayesian Modeling of the Mnemonic Similarity Task Using Multinomial Processing Trees.
使用多项式处理树对记忆相似性任务进行贝叶斯建模。
Behaviormetrika. 2023 Jul;50(2):517-539. doi: 10.1007/s41237-023-00193-3. Epub 2023 Jan 20.
4
Timing of Biomarker Changes in Sporadic Alzheimer's Disease in Estimated Years from Symptom Onset.散发性阿尔茨海默病从症状出现到估计年份的生物标志物变化时间。
Ann Neurol. 2024 May;95(5):951-965. doi: 10.1002/ana.26891. Epub 2024 Feb 24.
5
Highly accurate blood test for Alzheimer's disease is similar or superior to clinical cerebrospinal fluid tests.阿尔茨海默病的高精度血液检测在准确性上可与临床脑脊液检测相媲美或优于后者。
Nat Med. 2024 Apr;30(4):1085-1095. doi: 10.1038/s41591-024-02869-z. Epub 2024 Feb 21.
6
Biomarker Changes during 20 Years Preceding Alzheimer's Disease.阿尔茨海默病发病前 20 年的生物标志物变化。
N Engl J Med. 2024 Feb 22;390(8):712-722. doi: 10.1056/NEJMoa2310168.
7
The HOPE4MCI study: A randomized double-blind assessment of AGB101 for the treatment of MCI due to AD.HOPE4MCI研究:AGB101治疗阿尔茨海默病所致轻度认知障碍的随机双盲评估。
Alzheimers Dement (N Y). 2024 Jan 24;10(1):e12446. doi: 10.1002/trc2.12446. eCollection 2024 Jan-Mar.
8
Predicting progression to Alzheimer's disease dementia using cognitive measures.使用认知测量预测向阿尔茨海默病痴呆的进展。
Int J Geriatr Psychiatry. 2024 Feb;39(2):e6067. doi: 10.1002/gps.6067.
9
Early Detection of Amyloid-Related Changes in Memory among Cognitively Unimpaired Older Adults with Daily Digital Testing.认知正常的老年人群体通过日常数字测试进行淀粉样蛋白相关记忆改变的早期检测。
Ann Neurol. 2024 Mar;95(3):507-517. doi: 10.1002/ana.26833. Epub 2023 Dec 19.
10
Examining the diagnostic value of the mnemonic discrimination task for classification of cognitive status and amyloid-beta burden.检查助记符判别任务对认知状态和淀粉样-β负担分类的诊断价值。
Neuropsychologia. 2023 Dec 15;191:108727. doi: 10.1016/j.neuropsychologia.2023.108727. Epub 2023 Nov 7.